chrisvoncsefalvay/vaers-outcomes huggingface dataset:
4-16 Friday  2nd COVID shot, feeling ok. A little tired; 4-17 Saturday tired, low grade fever, achy; 4-18 Sunday Rash on tops of both feet, tired achy, low grade fever, chills; 4-19 Monday Fatigue, slight rash on torso, feet better, low grade fever, chills; 4-20 Tuesday Rash entire torso front and back small red raised blisters, fever 100+, fatigue, easily winded and tired, runny nose, contacted Doctor, told to wait 7 days to call back if symptoms don?t improve; 4-21 Wednesday Severe Rash on torso, arms, legs, buttocks, no pain or itching; 4-22 Thursday Rash spreading to all parts of the body from head to soles of feet, difficulty breathing, fever hard to manage 101-102, mouth sores, eyes bloodshot, Went to urgent care, Negative Rapid Covid test, put on 50 mg Prednisone and 1 tab claritin; 4-23 Friday Rash more red, blisters gone no white on torso, some white areas on legs, arms, and other parts of the body.  Breathing worse, coughing, chills, fever hard to manage 101-102, chills, no appetite, diarrhea, rash painful on sides of torso; 4-24 Saturday Went to ER for difficulty breathing, no unaffected skin on torso, general ill feeling, eyes still bloodshot, mouth sores, *Intravenous steroids, chest CT scan and xray showed inflamed lymph nodes, inflamed lung walls, no blood clots, bronchial walls thickening and faint peripheral ground glass opacities in the right lobe, mediastinal and right hilar lymphadenopathy as well as air-trapping in the right middle lobe and left upper lobe *strep test negative; 4-25 Sunday rash a little better after intravenous steroids, breathing worse, fever still 101-102 managing with tylenol and advil; 4-26 Monday Dermatology consult punch skin biopsy to rule out viral cause of rash, blood work done to rule out pneumonia, put on reducing course of prednisone 60/40/20/10/5 - Allergy consult no diagnosis; 4-27 Tuesday primary care doctor, added Symbocourt, rash peeling and flaking and painful, slowly receding, breathing still labored and difficult, no appetite, no energy, fatigued, eyes still bloodshot, mouth still sore and raw/canker sore like, ruled out any other cause diagnosed as vaccine reaction.  Advised to contact in two weeks if breathing it still difficult.
Patient received covid vaccinations for primary series on 9/20/21 and 10/18/2021. Patient was incorrectly administered booster pfizer vaccine on 2/1/22 by nurse.
Sensation of trouble swallowing - onset 2h after administration of vaccine. Chest tightness, but no reported trouble breathing. Tx: monitor, increase fluids, take BENADRYL, call 911 if worsens.
Hospitalized 01/27/2022; COVID-19 positive 1/4/2022 (no documentation just stated in d/c summary) documented COVID-19 positive 01/27/2022; fully vaccinated plus booster  Admission Date: 1/27/2022 Discharge Date:  02/01/2022 Admitting Physician:  PRIVACY Attending Physician: PRIVACY Discharge Clinician:  PRIVACY Primary Care Provider at Discharge: PRIVACY  Hospital Course:   Patient is a 73 y.o. male with past medical history significant for CHF, A. fib, s/p redo AVR due to Strep. Group B endocarditis 12/3/21, anemia, CAD, HTN who presented to ED with complaints of R knee pain and swelling.       Patient had recent prolonged admission 11/26-12/30 for chest pain, hypotension and renal failure requiring CRRT. He was on vent and pressors but was eventually weaned off both. Developed Strep. Group B endocarditis for which he completed course of Rocephin through 1/14. Was discharged to MFB for rehab. While at hospital he had a positive COVID test on 1/4 though was asymptomatic. Was d/c back home about a week ago.    About 3 days PTA he started having R knee pain and swelling. The pain in his right knee became more severe to the point where he could not ambulate secondary to the pain.  He notes that he was also unable to bend his knee secondary to the pain. He was also having R foot pain. He does have chronic distal phalanx thromboembolism of bilateral toes. Denies any drainage or foul smell from wounds. Notes that his wife changes his dressings and puts iodine on his wounds daily.    Upon arrival to the ED, patient had low grade fever but vitals were otherwise stable. Baseline blood work was obtained showing WBC 14.7, elevated ESR/CRP, minor hyponatremia of 131, stable chronic anemia. INR 1.9. Covid test persistently positive. Blood cultures were obtained. US RLE negative for DVT. XR R knee showing subtle new irregularity about lateral aspect of lateral tibial plateau w/ enlarged joint effusion. Ortho performed bedside arthrocentesis in ED. They did not feel it was consistent with septic arthritis at this time. Cultures negative, no crystals in fluid, blood uric acid low. Patient treated with Vanc for 3 days (MRSA screen negative) and Zosyn for 5 days. CRP improved from 169.1 to 68.8. Echocardiogram from 1/26 did now show any valvular vegetations. Evaluated by PT/OT who initially recommended acute rehab. PMR recommended home with home therapy. He is established with services already and this was verified
The patient woke up the morning after the vaccination not feeling well. By 11 am he felt bad enough that he went back to bed and stayed in bed all day. He was "down" about 13 hours. He had a fever of 101 F, achy, and chills. The following day he felt okay (day 2 after vaccine). Soreness at the site remained for several days.
episode high pitch screaming for 2-3hr since recv vax on 1DEC;diff to console;
pt recv vax;arm became red from elbow to shoulder joint; also swollen; arm very tender; woke up during sleep due to pain; seen PMD; to hosp;was told may be an abscess;on Keflex; knot size of golf ball; stings at times;
Patient with cognitive disabilities with confabulation.  Symptoms began in mid January 2004. Per dischary summary, pt experienced headaches, altered mental status, and liver cyst. Discharge summary on 05/05/04 states: encephalitis, E.coli infection, anemia, cognitive deficits, fever, bradycardia. Information fron Annual Follow-up report states patient continues to have memory difficulties. Patient is undergoing evaluation to exclude multiple sclerosis.
This spontaneous report was received from an 87 year old female consumer referring to herself. The patient's medical history included hypertension and allergy to penicillin. On 19-JUN-2013, the patient was vaccinated with a dose of ZOSTAVAX (lot # and Expiry date not reported). Other co-suspect medications included unspecified thyroid medication and unspecified low dose blood pressure medication. On 14-AUG-2015, the patient discovered a rash under her right breast. Since then, the patient developed the worst case of shingles while on the vaccine, that hospital has seen (herpes zoster). The patient was admitted to hospital on an unspecified date after passing out (syncope). The patient stated that she still was suffering from the shingles that were on her right breast, her back and armpit. The outcome of herpes zoster was reported as not recovered/not resolved. The outcome of syncope was unknown. Additional information is not expected as no information for follow up was provided.
Severe vitreous retraction in both eyes. First signs began 5/3/21 with flashes and floaters in right eye; saw doctor on 5/4 to learn of retraction beginning. Second visit 5/7 to monitor for retinal tears. Retraction completed in about 2 weeks leaving floating dark circle and mass of additional floaters in right eyesight. Third visit 6/11 to monitor. Left eye symptoms of flashes and floaters began 7/18 and saw doctor on 7/19 to confirm retraction had begun on left eye.  Retraction completed in about 2 weeks leaving another floating dark circle and another mass of additional floaters in left eyesight. 5th visit 8/10 to monitor for retinal tears. Sixth visit 9/2 to monitor. Doctor indicated he had never seen any person have their second eye have vitreous retraction so quickly after the first eye. Result is seemingly permanent impaired vision with two separate dark circles and two masses of floaters that all move separately across vision even with eyes closed. The effects are the worst when driving and viewing computer monitors, especially with light backgrounds. In addition to the vitreous retraction, the second adverse effect has been continual tinnitus. The heightened internal audible noise began 5/5/21 and is still present. It is at a level to be annoying, but not to the point of overpowering external noises. This item was reported to my primary physician on 5/14/21, but he indicated that there was nothing that could be done about it.
3/24/21 -Evening after shot  had fever 3/30/21- nausea (vomit, once) - evening 3/31/21/-fever and delirium - night 4/1/21- fever (101.5), sniffles, cough - night 4/2/21 - fever (101.5) in morning - given Advil, 11:00 a.m. fever reduced
I had pain in my lower left abdomen, along with a slight fever and chills. I was told by a telephone doctor to go to the emergency room where they did an examination. I was dignosed with sigmoid diverticulitis. From doctor's notes: "Patient presented to the ER on 12/18/2021 with cramping abdominal pain in the lower abdominal region with associated fever. CT scan at that time suggested acute diverticulitis with possible microperforation. Patient was started on antibiotics and responded well and was discharged on 12/19/2021".
This case was reported by a consumer via call center representative and described the occurrence of injection site pain in a adult female patient who received Shingrix for prophylaxis. Previously administered products included Shingrix with an associated reaction of pain in extremity (Arm soreness after receiving 1st dose on April 2018, see case US2018GSK181307). On 9th September 2018, the patient received the 2nd dose of Shingrix. On 9th September 2018, immediately after receiving Shingrix, the patient experienced injection site pain, injection site swelling and injection site warmth. On an unknown date, the outcome of the injection site pain, injection site swelling and injection site warmth were recovered/resolved. It was unknown if the reporter considered the injection site pain, injection site swelling and injection site warmth to be related to Shingrix. Additional details were provided as follows: The age at vaccination was not reported. The patient felt as if she had been kicked in the arm by a horse. The site was warm and very swollen and sore. This developed the same evening and it took three to four days to go away. For tolerance after 2nd dose of Shingrix, refer US2018GSK181307.
Dose administered after 30 days use by date; Moderna Covid-19 vaccine that was beyond its use-by date was given; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond its use-by date was given) and PRODUCT STORAGE ERROR (Dose administered after 30 days use by date) in a female patient of an unknown age who received mRNA-1273 (Spikevax) (batch no. 025L21B) for COVID-19 vaccination.     No Medical History information was reported.    On 17-Mar-2022, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 17-Mar-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond its use-by date was given). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Dose administered after 30 days use by date). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Moderna Covid-19 vaccine that was beyond its use-by date was given) and PRODUCT STORAGE ERROR (Dose administered after 30 days use by date) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter did not provide any causality assessments.   On 06 Feb 2022 the vial was initially stored in refrigerator, it mentioned that the vial did not undergo any temperature excursions. No concomitant medications were reported.  No treatment medications were reported.   This case was linked to MOD-2022-516063 (Patient Link).
Left Arm pain. Felt like it was deep bone pain; Left Arm pain. Felt like it was deep bone pain; Restricted ability to use arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 57 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administered in arm left, administration date 31Jul2021 09:15 (Lot number: FC3180) at the age of 57 years as dose 1, single for covid-19 immunization. Relevant medical history included: "Psoriatic Arthritis" (unspecified if ongoing); "High blood pressure" (unspecified if ongoing); "Asthma" (unspecified if ongoing); "Known allergies: Sulfa" (unspecified if ongoing). The patient took concomitant medications. Past drug history included: Morphine, reaction(s): "Known allergies". The following information was reported: PAIN IN EXTREMITY (non-serious), BONE PAIN (non-serious) all with onset 31Jul2021 11:00, outcome "not recovered" and all described as "Left Arm pain. Felt like it was deep bone pain"; LIMB DISCOMFORT (non-serious) with onset 31Jul2021 11:00, outcome "not recovered", described as "Restricted ability to use arm". Therapeutic measures were not taken as a result of pain in extremity, bone pain, limb discomfort.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient received Presciption Medicines within 2 weeks of vaccination. Prior to vaccination, the patient not diagnosed with COVID-19. Since the vaccination, the patient not tested for COVID-19.  No follow-up attempts are possible. No further information is expected.
Shortly after patient received the MOderna 1st dose, the clerk recognized he was not of proper age.  Our screener was late to work this morning and she checks all appointments' birthdates and eligibility.  The clerk assumed that check was already done.  His sister signed him up on line for the appointment, not the parents.  The 20 year old sister is a health care worker and had received the Pfizer vaccine and didn't know Moderna's age limit was 18.  The nurse that gave the dose did not check the birthdate either.
Infant developed bloody stools the night after vaccines given. Breastfed no history of blood in stool.
In the middle of the night, while I was asleep, I was awoken because my feet were intensely burning and itching. I do not have any other conditions except for Asthma and have never experienced this before. The burning and itching lasted for hours and were very intense and scary.
At 8 pm same day of vaccine, I had chills, very achy, bad headache and it lasted all night and in the morning I had nausea and headache.  By 11 am I felt much better, but was still achy, and weak for most of the next day.
Swollen, red, hot to touch around injection site. low grade fever, fatigue, muscle aches
This spontaneous report as received from an unknown age female patient refers to herself. The patient had taken LIDODERM ointment and acyclovir for shingles outbreaks in the past. The patient had a history of unspecified thyroid issues and had had a coma. The patient had shingles outbreaks when she was in her 20's (years). On 09-OCT-2012 the patient was vaccinated with a dose of ZOSTAVAX (lot#, expiration date not reported, "standard", subcutaneously). Concomitant therapies included levothyroxine sodium(manufacturer unknown), metoprolol, KLONOPIN and EFFEXOR. The patient still experienced shingles outbreaks after having the vaccine, however the outbreaks had been less severe lasting between 1-2 days and included very mild headaches, rash and sore throat. The patient explained that she had had 4 of there outbreaks in a row within this past year and felt that the outbreaks do occur more frequently than before she received the vaccine. Approximately on 28-OCT-2013 ("two weeks ago"), the patient developed a more severe shingles outbreak that included a rash on her left hip, hyper sensitivity, migraine, pain and sore throat, this reaction lasted for a longer timeframe and that on the 02-NOV-2013 or 03-NOV-2013 ("4th-5th day of this outbreak") the rash spread to her right hip. The severe reaction occurred after an unspecified thyroid issue. The patient sought medical attention via talking to the doctor. The patient took TYLENOL for treating the event. The outcome of the events was reported as recovered on 08-NOV-2013 ("three days ago"). Follow-up information was received which reported the patient's birthdate year was unable to be confirmed at this point. The patient was within the indicated age range to received the vaccine according to current prescribing information for ZOSTAVAX. Additional information has been requested.
No adverse event. Patient was given only the component part of pentacel which includes the DTaP and IPV only. the ActHIB was not administered.
3 days p/vax pt exp inj site rxn of redness,swelling,erythematous, itching & bumps. Rxn progressed down to elbow. No relief from Benadryl. Pt recvd HepA & HepB vax previous week.Pt also recvd oral Typhoid.
After 1st dose: - Fatigue - Fever (100.9) - Headache - Nausia - Vomiting - Ache -Tired
OVERDOSE (RECEIVED 2.5ML OF THE JANSSEN COVID-19 VACCINE); OFF LABEL USE; This spontaneous report received from a health care professional concerned a 31 year old male. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1822809, and expiry: 07-MAR-2022) dose was not reported, administered on 21-NOV-2021 for prophylactic vaccination. No concomitant medications were reported. On 21-NOV-2021, the patient experienced overdose (received 2.5ml of the janssen covid-19 vaccine). On 21-NOV-2021, the patient experienced off label use. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the overdose (received 2.5ml of the janssen covid-19 vaccine) and off label use was not reported. This report was non-serious. This case, from the same reporter is linked to 20211220916,  20211220233, 20211220262, 20211220216, 20211220460, 20211220206, 20211219686, 20211220527, 20211220537, 20211220552, 20211220619, 20211220697, 20211220754, 20211220764, 20211219714, 20211219731, 20211219926, 20211219701 and 20211220948.
PATIENT'S HUSBAND CALLED STATING THAT PATIENT'S ARM WAS SWOLLEN SLIGHTLY FROM INJECTION SITE, DOWN THE BACK OF THE ARM TO HER ELBOW AND WAS WARMER THAN THE REST OF THE BODY. THE SWOLLEN ARE WAS "HARD AS A ROCK" AND SHE HAD COMPLAINED THROUGHOUT THE DAY THAT HER ARM WAS PAINFUL. PATIENT HAD TAKEN ALIEVE THROUGHOUT THE DAY, AND IT WAS SUGGESTED THAT SHE APPLY ICE TO THE SWOLLEN ARE FOR SHORT PERIODS AND TAKE BENADRYL IF SHE FELT NEEDED. IF THE ARE DID NOT IMPROVE SHE SHOULD TRY CALLING AN ON CALL PHYSICIAN FOR FURTHER TREATMENT OR IF NECESSARY SEEK MORE URGENT MEDICAL TREATMENT IF THEY FELT IT WAS TO THAT EXTENT. ALSO ADVISED FOR A FOLLOW UP CALL THE NEXT DAY TO SEE WHAT THE PROGRESS WAS ON THE REACTION.
pt recv vax; to er at 4:30pm;v,d,T 104,2 Ax;sz started at noon;gave suppository & apap & fever down to 101.8;MD said strep throat & did not say it was rxn to vax; no labs work;
Pt recvd Td vax & immed p/inject site became red & swollen; 10 days later pt returned to ER & was found to have an abscess;
nauseas; fever 102°F; Chills; Headache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseas), PYREXIA (fever 102°F), CHILLS (Chills) and HEADACHE (Headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Hypertension.   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient experienced NAUSEA (nauseas), PYREXIA (fever 102°F), CHILLS (Chills) and HEADACHE (Headache). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and IBUPROFEN (ADVIL [IBUPROFEN]) at an unspecified dose and frequency. At the time of the report, NAUSEA (nauseas), PYREXIA (fever 102°F), CHILLS (Chills) and HEADACHE (Headache) had not resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Blood pressure measurement: low (Low) Lowered. On an unknown date, Pyrexia: 102 (Inconclusive) 102 F.         No concomitant medications were reported.  Action taken with mRNA-1273 in response to the events was not applicable.   The caller was a patient who was warm transferred from costumer care under case number MOD21-00147687. The patient received both doses of the Moderna COVID-19 Vaccine and reported side effects after the second dose. The patient has hypertension and started monitoring the blood pressure after the vaccination and it's been lowered. The patient wanted to know if Is it related with being vaccinated?
patient got a rash near his elbow that went up diagonal around his arm, but not at or near the injection site
pt recv ax 22AUG95 & 1MAY96 pt exp very mild rash on back & face;
Pt went into sz activity @ home on 10FEB94 mom took pt to ER @ hosp;
Case number PHEH2014US025069, is an initial spontaneous report received from a nurse on 09 Dec 2014. This report refers to a 65 year old female patient. Medical history and concomitant medication were not reported. She was vaccinated with FLUVIRIN (batch number: 145701) intramuscularly at a dose of 0.5 ml on 20 Oct 2014. Nurse reported that patient received FLUVIRIN that was at 49 degree F 12 times over a period of 34 days. The temperature excursions began around 16 Oct 14. 12 separate temperature excursions lasting 30 minutes each in which the temperature was 46-49 degree F during each of those excursions. No adverse event was reported following this maladministration. No further information was provided.
Chills, headaches, nausea, vomiting diarrhea, weakness , coughing
L shoulder, upper arm swelling, edema, taut/tight skin, and some eythema.
Pt became dizzy, felt faint approx 4 minutes after receiving tetanus injection. Pt was diaphoretic, pale, and anxious. Pt placed in prone position, given juice and recovered in 20 minutes.
Maternal exposure during pregnancy; This spontaneous prospective pregnancy case was reported by a physician and describes the occurrence of MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) in a 34-year-old female patient (gravida 1) who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 002A21A and 012M20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. The patient's last menstrual period was on an unknown date and the estimated date of delivery was 30-Oct-2021. On an unknown date, the patient experienced MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy). At the time of the report, MATERNAL EXPOSURE DURING PREGNANCY (Maternal exposure during pregnancy) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. Treatment information was not provided. Lab details were not provided.